Thursday, October 30, 2025

 

‘Broken’ genes a common factor in marsupial fur colour



The distinctive coloured fur of two of Australia's rarest marsupials could be caused by 'broken' pigment genes, new research from La Trobe University has found.




La Trobe University

Dr Charles Feigin and a rare marsupial mole 

image: 

Dr Charles Feigin and a rare marsupial mole

view more 

Credit: Dr Charles Feigin




The distinctive coloured fur of two of Australia's rarest marsupials could be caused by 'broken' pigment genes, new research from La Trobe University has found.

The elusive desert-dwelling marsupial mole and the black-coated morph of the endangered eastern quoll are two of a growing number of marsupials showing common colour oddities.

In many species, colour oddities like melanism and xanthism are considered chromatic disorders and are detrimental to an animal’s survival.

But in research published in Biology Letters, scientists discovered that for a growing number of marsupials, colour morphs are common or even universal across all members of their species.

In black morph eastern quolls, a missing stretch of DNA disables the Agouti Signalling Protein (ASIP) gene, which normally leads to the production of light yellow-to-red pigment called pheomelanin.

Remarkably, a nearly identical stretch of DNA was recently found to be missing in the Tasmanian devil, a close sister species to the quolls that also has blackish brown background coat. By comparing sequences around these DNA deletions, the researchers showed that both quolls and devils have lost their ASIP genes independently, a phenomenon called convergent evolution.

In parallel, the team examined the enigmatic and rarely-seen marsupial mole, a ‘sand swimming’ mammal native to Australia's deep deserts using their recently-released genome assembly.

Marsupial moles are rare among mammals for have a ‘xanthic’ coat - a light-yellow colour caused by the absence of dark eumelanin. In this species, a gene called the Melanocortin 1 Receptor (MC1R), responsible for driving eumelanin deposition, has a mutation that cuts it short and prevents it from functioning.

ASIP and MC1R are known to be critical genes controlling fur colour in mammals, and together function like a molecular ‘switch’ between eumelanin and pheomelanin production.

Study lead Dr Charles Feigin said normally, MC1R is periodically shut off by ASIP, leading to alternating dark and dark bands within individual hair shafts, creating the common grey-to-brown coats seen in most mammals. When either side of the switch breaks, this balance collapses, leading to only one pigment being produced.

“While the exact evolutionary consequences of coat colour variation in marsupials remain to be discovered, ‘broken genes’ seem to be an important player in how they come about,” he said.

The full paper can be read here: Loss-of-function mutations in ASIP and MC1R are associated with coat colour variation in marsupials

DOI: https://doi.org/10.1098/rsbl.2025.0302

Dr Feigin is available for interview.

Media contact

Charisse Ede

c.ede@latrobe.edu.au, 0404 030 698

 

Turning waste into clean water: Magnetic carbon materials remove toxic pollutants from wastewater




Biochar Editorial Office, Shenyang Agricultural University
Sustainable carbon materials for magnetic adsorbent-based pentachlorophenol removal from wastewater 

image: 

Sustainable carbon materials for magnetic adsorbent-based pentachlorophenol removal from wastewater

view more 

Credit: Tunnisha Dasgupta, Himadri Rajput, Pubudi Perera, Xiaohong Sun & Quan (Sophia) He





As global water resources face increasing pressure from industrial and agricultural activities, scientists are looking for innovative ways to clean and reuse wastewater sustainably. Researchers from Dalhousie University have now developed a simple and eco-friendly method to turn agricultural and forestry waste into powerful magnetic materials that can effectively remove toxic chemicals from water.

The study, published in Sustainable Carbon Materials, introduces magnetic carbon adsorbents made from two common waste products: flax shives and eucalyptus sawdust. These materials were converted into “hydrochar” through a process called hydrothermal carbonization, which transforms biomass into carbon-rich solids under heat and pressure. By adding iron during the process, the researchers created magnetic hydrochars that can be easily separated from treated water using a magnet, eliminating the need for costly filtration.

The new materials demonstrated outstanding performance in removing pentachlorophenol (PCP), a persistent and highly toxic pollutant commonly found in industrial and agricultural wastewater. Under optimal conditions, the flax-based hydrochar removed up to 95 percent of PCP, while the eucalyptus-based version achieved nearly 89 percent removal. Both materials maintained high efficiency through six reuse cycles, showing excellent stability and minimal loss of performance. Importantly, no iron leakage was detected, confirming that the materials are safe and environmentally friendly.

“Our goal was to develop a sustainable, low-cost, and reusable solution for treating wastewater contaminated with harmful chemicals,” said lead author Tunnisha Dasgupta, a researcher at Dalhousie University’s Faculty of Agriculture. “By using agricultural and forestry residues, we are not only cleaning water but also giving new value to waste materials.”

The study highlights how simple modifications—such as incorporating iron during carbonization—can dramatically enhance the surface area, porosity, and adsorption capacity of bio-based materials. The resulting magnetic properties make them easy to collect and reuse, reducing both cost and environmental impact.

Senior author Dr. Quan (Sophia) He explained that the innovation represents a step forward for circular economy practices in water treatment. “This work shows how we can turn organic waste into advanced materials that protect our environment,” she said. “The magnetic hydrochars are scalable, efficient, and align with global goals for sustainable water management.”

By combining waste valorization with effective pollutant removal, the research provides a promising pathway toward greener wastewater treatment technologies that can benefit both industry and the environment.

 

=== 

Journal reference: Dasgupta T, Rajput H, Perera P, Sun X, He Q. 2025. Sustainable carbon materials for magnetic adsorbent-based pentachlorophenol removal from wastewater. Sustainable Carbon Materials 1: e003  https://www.maxapress.com/article/doi/10.48130/scm-0025-0003   

 

=== 

About Sustainable Carbon Materials:

Sustainable Carbon Materials is a multidisciplinary platform for communicating advances in fundamental and applied research on carbon-based materials. It is dedicated to serving as an innovative, efficient and professional platform for researchers in the field of carbon materials around the world to deliver findings from this rapidly expanding field of science. It is a peer-reviewed, open-access journal that publishes review, original research, invited review, rapid report, perspective, commentary and correspondence papers.

Follow us on FacebookX, and Bluesky

 

World Health Organization’s priorities shaped by its reliance on grants from donor organisations such as the Gates Foundation




Over half of Gates Foundation grants to WHO have targeted polio and vaccination; but key WHO priorities like non-communicable diseases and strengthening health systems remain underfunded




BMJ Group





The World Health Organization’s (WHO’s) priorities are being skewed by its increasing reliance on donations from organisations such as the Gates Foundation (previously known as the Bill and Melinda Gates Foundation), which must be spent on specific health challenges favoured by the donors, suggests a study published in the journal BMJ Global Health.

Between 2000 and 2024, more than half of the US $5.5 billion donated by the Gates Foundation to WHO was directed toward vaccine-related projects and polio, while relatively little funding was spent on other issues considered to be important by WHO.

The Gates Foundation has become the WHO’s second biggest source of funding in recent years contributing 9.5% of WHO’s revenues between 2010 and 2023. Its largest funder was the United States, but earlier this year the US announced it would withdraw from WHO from January 2026. Germany and the UK were third and fourth largest WHO funders, respectively.

Although it is widely assumed that the Gates Foundation’s financial power allows it to exert influence over WHO’s work programme, little research has been undertaken to track exactly how its grants are spent.

To address this, the authors extracted data from the Gates Foundation website on all its grants to WHO between 2000 and 2024 to determine the number and value of grants, and the diseases, health issues and activities they funded.

Between 2000 and 2024, the Gates Foundation made 640 grants worth US $5.5 billion to WHO. In total 6.4% of all grants made by the Gates Foundation during this period went to WHO.

More than 80% of the Gates Foundation’s grants to WHO (US $4.5 billion) were targeted at infectious diseases and almost 60% (US $3.2 billion) were spent on polio. More than half of the Foundation’s money (US $2.9 billion) was used to fund vaccine programmes and related projects.

Relatively little funding from the Gates Foundation was directed towards non-communicable diseases, strengthening health systems, and broader determinants of health, despite their importance to WHO strategy and global health more generally.

Just US $11.8 million (0.2%) was spent on water and sanitation and US $37.4 million (0.7%) on health systems strengthening. Less than 1% of the Foundation’s funding went towards non-communicable diseases, despite them being responsible for 74% of global deaths with 77% of these deaths occurring in low- and middle-income countries.

WHO’s budget comes from two sources – assessed contributions from member states, calculated according to a country’s wealth and population, plus voluntary contributions or extra-budgetary funding from member states and non-state organisations. Around nine-tenths income comes from voluntary or extra-budgetary funding, and almost all of this money is ‘earmarked’, i.e. given on the condition that it funds activities and projects defined by the donor.

The way WHO is funded limits its ability to fulfil its strategic goals, the authors say. 

“Assessed contributions from member states are nowhere near the level needed to fund its strategic priorities, so WHO must rely on earmarked voluntary contributions from donors,” they say. “Consequently, activities and areas that donors favour receive more resources than are required while those they are not interested in do not get enough.”

And the situation could worsen if the United States – WHO’s largest donor – carries through with its threat, announced in January 2025, to withdraw from WHO.

While it is easy to blame major donors like the Gates Foundation for undermining WHO’s independence by pursuing its agenda through WHO, the authors say: “We should not, however, lose sight of the fact that it is the member states’ failure to increase assessed contributions in line with WHO’s needs over the last four decades that has created a situation in which the organisation is forced to rely on voluntary contributions from donors.”

They add: “WHO has asked for more flexible and sustainable funding, warning that without fundamental changes to the way it is financed, it will be unable to achieve its strategic aims. If the member states continue to ignore these exhortations, then WHO will remain vulnerable to the influence of external donors and will struggle to address the full spectrum of contemporary global health challenges.”

One in ten people without coeliac disease or wheat allergy report sensitivity to gluten or wheat



Self-reported gluten/wheat sensitivity is more common in women and people with irritable bowel syndrome, anxiety and depression




BMJ Group





Around one in ten people worldwide report gastrointestinal and other symptoms such as fatigue and headache after eating foods containing gluten or wheat despite not having a diagnosis of either coeliac disease or wheat allergy, finds a large systematic review and meta-analysis published online in Gut.

These people have a condition known as non-coeliac gluten/wheat sensitivity (NCGWS), which appears to be more common in women and associated with irritable bowel syndrome, anxiety and depression.  

Symptoms of NCGWS tend to improve when gluten or wheat is avoided and recur when foods containing them are returned to the diet. However, in contrast to coeliac disease and wheat allergy, the disease process underpinning NCGWS is unclear and it has no specific associated blood markers, making diagnosis challenging.

Currently NCGWS is diagnosed by excluding coeliac disease and wheat allergy in individuals who report adverse symptoms after eating gluten or wheat, and little is known about the prevalence and presenting clinical features.

To address this, the authors identified all studies published between 2014 and 2024 evaluating the prevalence of self-reported NCGWS in the general population. Twenty five studies including 49,476 participants from 16 countries met the inclusion criteria and these data were extracted for use in their pooled analysis.

The results of this analysis showed the overall prevalence of self-reported NCGWS was 10.3% but that distinct differences in prevalence were evident between individual countries. Prevalence varied from 0.7% in Chile to 23% in the UK and 36% in Saudi Arabia.

The data also revealed that four in ten people reporting NCGWS followed a gluten-free diet to avoid gastrointestinal and other troublesome symptoms, often doing so in the absence of formal medical advice or a diagnosis.

The most common symptoms reported by participants were bloating (71%), abdominal discomfort (46%), abdominal pain (36%) and fatigue (32%). Other symptoms reported included diarrhoea, constipation, headache and joint pain.

In addition, self-reported NCGWS was significantly more common in women and significantly more likely to occur in people reporting anxiety, depression and irritable bowel syndrome.

The authors acknowledge the study had several limitations including its reliance on self-reporting of NCGWS by participants, that some of the authors had contributed to a subset of studies included in the meta-analysis, and that substantial differences in prevalence between the studies included could not be fully explained by regression analyses. They suggest these differences in prevalence could reflect variability in diagnostic criteria and confounding factors or be true differences in prevalence across populations and countries.

Nevertheless, the authors conclude, “Self-reported non-coeliac gluten/wheat sensitivity affects approximately one in ten people worldwide, with a considerable geographical variation and strong association with female sex, psychological distress and irritable bowel syndrome.”

They add that non-coeliac gluten/wheat sensitivity needs to be recognised within the disorders of the gut-brain interaction framework – a neurogastroenterology concept that emphasises the bidirectional communication between the gut and the brain – and symptom-based diagnostic criteria developed “to guide a more tailored management approach focusing on individual symptom patterns and dietary triggers beyond gluten and to reduce unnecessary dietary restriction in this common condition”.